Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AVITA Medical Inc RCEL

Healthcare Biotechnology
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RCEL)

AVITA Medical to Announce First Quarter 2024 Financial Results

GlobeNewswire 4 days ago

AVITA Medical Updates Expected First Quarter 2024 Revenue

GlobeNewswire 9 days ago

AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement

GlobeNewswire February 29, 2024

AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference

GlobeNewswire February 29, 2024

AVITA Medical to Host Investor Webinar Briefing

GlobeNewswire February 23, 2024

AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

GlobeNewswire February 22, 2024

AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 1, 2024

AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

GlobeNewswire January 10, 2024

AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

GlobeNewswire January 10, 2024
View More News ››

Opinion & Analysis (NDAQ:RCEL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RCEL)

$AVMXY Avita Medicals ReCell gets FDA approval!

https://finance.yahoo.com/news/avita-medical-announces-fda-approval-001200888.html
EricsShop - September 21, 2018

Re:Zacks Investment Research - Initiated Coverage

http://www.youtube.com/watch?v=MHHZ0Yd2eyo
bent88 - July 17, 2013

Re:Recell-Spray On Skin-Regenerative Medicine-PhaseIII FDA Trials

Hello All, Aussie minow trading on the OTC market, huge potential. FDA trials sponsored by the DOD and AFIRM. http://www.avitamedical...
bent88 - July 5, 2013
View more Bullboard ››

Geologica Resource Corp.

Geologica Resource Corp.

Geologica Resource Corp. is an exploration and development company focused on the acquisition, exploration and development of ...
View More »